JP2018521031A5 - - Google Patents

Download PDF

Info

Publication number
JP2018521031A5
JP2018521031A5 JP2017564367A JP2017564367A JP2018521031A5 JP 2018521031 A5 JP2018521031 A5 JP 2018521031A5 JP 2017564367 A JP2017564367 A JP 2017564367A JP 2017564367 A JP2017564367 A JP 2017564367A JP 2018521031 A5 JP2018521031 A5 JP 2018521031A5
Authority
JP
Japan
Prior art keywords
vitamin
parts
configuration
composition
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017564367A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018521031A (ja
Filing date
Publication date
Priority claimed from CN201510321294.2A external-priority patent/CN106265696A/zh
Application filed filed Critical
Publication of JP2018521031A publication Critical patent/JP2018521031A/ja
Publication of JP2018521031A5 publication Critical patent/JP2018521031A5/ja
Pending legal-status Critical Current

Links

JP2017564367A 2015-06-12 2016-06-06 胃腸系運動を刺激するための薬物の製造におけるマルチビタミン組成物の使用 Pending JP2018521031A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510321294.2 2015-06-12
CN201510321294.2A CN106265696A (zh) 2015-06-12 2015-06-12 使用复合维生素b、c组合物促进胃肠系统动力的方法
PCT/CN2016/084938 WO2016197889A1 (zh) 2015-06-12 2016-06-06 复合维生素组合物在制备促进胃肠系统动力的药物中的用途

Publications (2)

Publication Number Publication Date
JP2018521031A JP2018521031A (ja) 2018-08-02
JP2018521031A5 true JP2018521031A5 (cg-RX-API-DMAC7.html) 2019-07-04

Family

ID=57502901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017564367A Pending JP2018521031A (ja) 2015-06-12 2016-06-06 胃腸系運動を刺激するための薬物の製造におけるマルチビタミン組成物の使用

Country Status (8)

Country Link
US (1) US10881639B2 (cg-RX-API-DMAC7.html)
EP (1) EP3308787A4 (cg-RX-API-DMAC7.html)
JP (1) JP2018521031A (cg-RX-API-DMAC7.html)
CN (2) CN111803514A (cg-RX-API-DMAC7.html)
AU (1) AU2016276482A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017026834A2 (cg-RX-API-DMAC7.html)
CA (1) CA2989214A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016197889A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079008A (zh) 2016-11-23 2018-05-29 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物
CN108567792A (zh) * 2017-03-07 2018-09-25 上海泽生科技开发股份有限公司 一种治疗阿尔茨海默病的复合维生素组合物
CN115581699A (zh) * 2018-04-28 2023-01-10 上海泽生科技开发股份有限公司 促进胃肠系统动力的复合维生素组合物及其制备方法
EP3801498A1 (en) * 2018-06-08 2021-04-14 DSM IP Assets B.V. Methods and compositions to support the growth or maintenance of oxygen-sensitive bacteria in the gastrointestinal tract
KR20210101268A (ko) * 2018-12-11 2021-08-18 디에스엠 아이피 어셋츠 비.브이. 장 건강에 유익한 리보플라빈의 용도
CN115003172A (zh) * 2020-02-12 2022-09-02 帝斯曼知识产权资产管理有限公司 抗氧化剂至肠道的直接递送

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1094824B1 (en) * 1998-06-10 2006-04-05 Albert B. Crum Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system
US20080213395A1 (en) * 2004-10-14 2008-09-04 Adventures Plus Pty Ltd Method for the Treatment of Gastrointestinal and Other Disorders with an Admixture of Vitamins
JP2012019691A (ja) * 2010-06-17 2012-02-02 Morinaga Milk Ind Co Ltd 腎疾患患者用経口栄養組成物
CN108420827A (zh) * 2010-07-22 2018-08-21 雷文制药有限公司 包含磁偶极子稳定化溶液的组合物及其用途
CN104337813A (zh) * 2013-07-23 2015-02-11 上海泽生科技开发有限公司 使用维生素b组合物促进胃肠系统动力的方法
CN104256652A (zh) 2014-10-08 2015-01-07 李明刚 一种口服复合维生素纳米脂质体

Similar Documents

Publication Publication Date Title
US8349376B1 (en) Anti-dementia regimen
JP2018534348A5 (cg-RX-API-DMAC7.html)
FI3641819T3 (fi) Kannabidiolin käyttö tuberoosisklerooosikompleksin hoitoon
FI3250182T3 (fi) Dispergoituvia koostumuksia
AR088195A1 (es) Composiciones farmaceuticas de n-metil-2-[3-(e)-2-piridin-2-il-vinil)-1h-indazol-6-ilsulfanil]-benzamida
JP2004519488A5 (cg-RX-API-DMAC7.html)
JP2018530592A5 (cg-RX-API-DMAC7.html)
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
JP2015131825A5 (cg-RX-API-DMAC7.html)
JP2020528888A5 (cg-RX-API-DMAC7.html)
RU2018114447A (ru) Введение дейтерированных усилителей cftr
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
IL251413B2 (en) Composition of injectable buprenorphine
BR112017010953A2 (pt) composição farmacêutica
JP2023011769A5 (cg-RX-API-DMAC7.html)
JP2016530291A5 (cg-RX-API-DMAC7.html)
BR112017010933A2 (pt) composição farmacêutica
ECSP15033787A (es) Nueva formulación granular de disolución rápida que tiene solubilidad mejorada
GEP20217266B (en) CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
SA519410841B1 (ar) تركيبة مستحلب نانو زيت في ماء من كلوبيتاسول
HRP20210010T1 (hr) Injekcijske farmaceutske formulacije lefamulina
MY168531A (en) Medicament form for release of active ingredients
AR080052A1 (es) Composiciones que comprenden productos de azucar cisteina, bebida, contenedor de bebida, metodo
CN110520135A (zh) 维生素组合物在制备用于预防、治疗或延迟阿尔茨海默病的药物中的用途
HRP20231448T1 (hr) Primjena delgocitiniba za liječenje kroničnog ekcema ruku